MyFinsight
Home
About
Contact
syre: the income statement
Download
Download image
Net loss
-$11,183K
Other income
(expense), net
$40,326K
Interest income
$5,379K
Loss before income
tax expense
-$11,183K
Total other income
(expense)
$45,705K
Loss from operations
-$56,888K
Total operating
expenses
$56,888K
General and
administrative
$11,641K
Research and development
$45,247K
Back
Back
Income Statement
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)